HEALTHICHOL Trademark

Trademark Overview


On Monday, July 2, 2007, a trademark application was filed for HEALTHICHOL with the United States Patent and Trademark Office. The USPTO has given the HEALTHICHOL trademark a serial number of 77220066. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, July 30, 2008. This trademark is owned by Goldshield Group Plc. The HEALTHICHOL trademark is filed in the Pharmaceutical Products category with the following description:

Allergy tablets; Antibiotic tablets; Laundry sanitizer tablets; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Sleeping pills/tablets; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin tablets; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Insect repellent in candle form; Insect repellent in the nature of a lamp oil; Medicinal herbs in dried or preserved form; Mold inhibitors for treating mold growth in and around buildings; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Parapharmaceutical products for use ...
healthichol

General Information


Serial Number77220066
Word MarkHEALTHICHOL
Filing DateMonday, July 2, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, July 30, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 6, 2007

Trademark Statements


Goods and ServicesAllergy tablets; Antibiotic tablets; Laundry sanitizer tablets; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Sleeping pills/tablets; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin tablets; In vitro gender prediction test kit; In-vitro ovulation prediction test kit for home use; Insect repellent in candle form; Insect repellent in the nature of a lamp oil; Medicinal herbs in dried or preserved form; Mold inhibitors for treating mold growth in and around buildings; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical solutions used in dialysis; Preparations for detecting mutation in prion genes for medical purposes; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Alloys of precious metal for use in dentistry and dentistry technology; Anti-microbial additive for compounds used in the manufacture of garden hoses; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Chemically treated papers for use in the detection of fecal occult blood; Contrast media for in-vivo imaging; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Radioactive substances for use in nuclear medicine; Sanitizers for use in institutional and industrial areas; Soy protein for use as a nutritional ingredient in various powdered and ready-to-drink beverages; Stimulatory medications for use in weight reduction programs; Synthetic cholesterol mainly for use in growing cell cultures; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 5, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGoldshield Group Plc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCroydon Surrey
GB

Party NameGoldshield Group Plc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCroydon Surrey
GB

Trademark Events


Event DateEvent Description
Thursday, October 23, 2008UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, September 30, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, September 30, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 11, 2008ASSIGNED TO EXAMINER
Monday, February 25, 2008UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, January 29, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 6, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 17, 2007NOTICE OF PUBLICATION
Tuesday, October 2, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 1, 2007ASSIGNED TO LIE
Thursday, August 30, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 29, 2007ASSIGNED TO EXAMINER
Thursday, July 5, 2007NEW APPLICATION ENTERED IN TRAM